Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

I-Mab and VMS Partner to IPO a SPAC in HK for a China Life Science Company

RemeGen Stages $410 Million Shanghai IPO; Trades Lower

OBiO Completes Shanghai IPO for Gene/Cell CDMO Services; Trades 67% Higher

Recbio Plans to Raise $98 Million in a Hong Kong IPO for Vaccines

Lepu Completes $116 Million HK IPO; Trades Flat in Opening Sessions

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022